Tue, 19 Aug 2025

Tue, 19 Aug 2025 Viking Therapeutics shares fall 40% on disappointing obesity pill trial data

The results could reinforce the dominance of Eli Lilly and Novo Nordisk in the booming market for weight loss and diabetes drugs.

  >>


Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025